id588673743
“We have decided that we are not going to do certain [clinical] trials … because it is becoming financially not viable,” Roche CEO Thomas Schinecker told reporters in July. That same day, Schinecker told CNBC that “there is an environment now that’s starting to emerge, that, you know, certain medicines would not make it.” In response to a request for comment from us, Roche disputed the gains that it made from the tax cuts, but did not provide details.
✏️ Because of new govt regulations and laws that require negotiating the costs of drugs, big pharma are employing some shady techniques under the guise of “financial unviability”.
Link to original
Remember, they’re making record profits from tax cuts and overall huge drug prices. The regulations are affecting a number of drugs, not all of them.
Instead, they will slow down r&d, prevent new drug releases, harm the public good, and do whatever it takes to protest the new laws.
🔗 View Highlight